4/A
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-053346
Director bought 55,555 shares at $18.00 ($999,990)
- Director acquired 6,414,356 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORONSKY ARNOLD L Director | 2020-09-25 | Purchase | +55,555 | $18.00 | $999,990 | 55,555 | I: show line 1 in the form |
| ORONSKY ARNOLD L Director | 2020-09-29 | Conversion | +1,620,101 | 1,675,656 | I: show line 2 in the form | ||
| ORONSKY ARNOLD L Director | 2020-09-29 | Conversion | +3,488,398 | 5,164,054 | I: show line 3 in the form | ||
| ORONSKY ARNOLD L Director | 2020-09-29 | Conversion | +1,040,654 | 6,204,708 | I: show line 4 in the form | ||
| ORONSKY ARNOLD L Director | 2020-09-29 | Conversion | +265,203 | 6,469,911 | I: show line 5 in the form | ||
| Open-market purchases · 55,555 sh · avg $18.00 · $999,990 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ORONSKY ARNOLD L Director | 2020-09-29 | Conversion · Series Seed Preferred Stock | −1,620,101 | 0 | I: show line 6 in the form | |||||
| ORONSKY ARNOLD L Director | 2020-09-29 | Conversion · Series A Preferred Stock | −3,488,398 | 0 | I: show line 7 in the form | |||||
| ORONSKY ARNOLD L Director | 2020-09-29 | Conversion · Series B Preferred Stock | −1,040,654 | 0 | I: show line 8 in the form | |||||
| ORONSKY ARNOLD L Director | 2020-09-29 | Conversion · Series C Preferred Stock | −265,203 | 0 | I: show line 9 in the form |
Loading xslF345X03/doc4a.xml…